Research Tracker›Biomarker Atlas›Gulf War Illness›Interleukin-8 (IL-8 / CXCL8)

Interleukin-8 (IL-8 / CXCL8) in Gulf War Illness

Interleukin-8 (IL-8 / CXCL8), also described as Chemokine, belongs to the inflammatory group of Gulf War Illness (GWI, Gulf War Syndrome) markers and is reported to be raised relative to healthy Gulf War veteran controls. Clinically, it has been associated with neutrophil activation. This entry summarises Johnson et al. 2016. Group-level associations like this do not translate into an individual diagnostic cut-off.

↑ ElevatedInflammatoryLOINC 33211-4

Summary

Direction in Gulf War Illness↑ Elevated — higher than in the comparison group
CategoryInflammatory
Also described asChemokine
Compared againstHGV (healthy Gulf War veteran controls)
Associated symptomsNeutrophil activation
Test typeBlood test (serum / plasma / whole blood)
LOINC code33211-4
SourceJohnson et al. 2016 — doi:10.1371/journal.pone.0157855
Condition atlasGulf War Illness Biomarker Atlas

Other conditions where Interleukin-8 (IL-8 / CXCL8) is reported

Atlas entryDirectionCompared against
Interleukin-8 (IL-8) in Long COVID↑ elevatedvs HC
Interleukin-8 (IL-8 / CXCL8) in ME/CFS↕ inconsistentvs HC
IL-8 in PACVS↑ elevatedvs HC

See the cross-condition hub: Interleukin-8 (IL-8 / CXCL8) across conditions.

Trials, interventions and tests

In clinical-trial registrations this marker maps to the outcome term Assessment of Changes in Exosome/Cytokine/Chemokine Testing (4 registered trials use a matching outcome measure).

Clinical trials using Interleukin-8 (IL-8 / CXCL8) as an outcome

NCT05833217Recruiting
Obesity, Insulin Resistance, and PASC: Persistent SARS-CoV-2
Outcome measure: Rate of Inflammatory Gene Expression in Adipose Tissue
NCT06535165Completed
Effect of Red Beetroot Juice Intake in Adults With Long COVID-19
Outcome measure: Changes in the concentration of circulating inflammatory mediators
Treatment of Long COVID Symptoms Utilizing Autologous Stem Cells Following COVID-19 Infection
Outcome measure: Assessment of Changes in Exosome/Cytokine/Chemokine Testing
VSL#3® vs Placebo in the Treatment of Fatigue and Other Symptoms in Long Covid (DELong#3)
Outcome measure: Analysis of PBMC and Serum Expression of inflammatory mediators at baseline (t0) and after 4 weeks of treatment (t4)

Commercial test availability

Interleukin-8 (IL-8) — specialty laboratory test.

Links are for reference only; availability, specimen requirements and coverage vary by location.

Related Inflammatory markers in Gulf War Illness

Full list: Gulf War Illness Biomarker Atlas.

Frequently asked questions

Is Interleukin-8 (IL-8 / CXCL8) high or low in Gulf War Illness?

Elevated. Studies summarised in the OSMF atlas report higher Interleukin-8 (IL-8 / CXCL8) in Gulf War Illness than in healthy Gulf War veteran controls. Source: Johnson et al. 2016.

What symptoms is Interleukin-8 (IL-8 / CXCL8) associated with in Gulf War Illness?

The cited literature associates this marker with Neutrophil activation. These are population-level associations and do not mean the marker causes the symptoms.

Which test measures Interleukin-8 (IL-8 / CXCL8)?

It is measured as a blood test (serum / plasma / whole blood). The standard laboratory code is LOINC 33211-4. Commercial laboratories such as Quest Diagnostics, LabCorp list an orderable assay.

Is one abnormal Interleukin-8 (IL-8 / CXCL8) result diagnostic of Gulf War Illness?

No. No single biomarker is diagnostic of Gulf War Illness. Interleukin-8 (IL-8 / CXCL8) findings come from group comparisons, overlap considerably between patients and controls, and vary with study design, timing and comparison group. A result should be interpreted by a clinician alongside symptoms, history and other tests.

Is Interleukin-8 (IL-8 / CXCL8) specific to Gulf War Illness?

No. The same marker is also reported in Long COVID, ME/CFS, PACVS in this atlas, so it reflects shared biology (for example inflammation or vascular stress) rather than a condition-specific signature.

Cite this page

Open Source Medicine Foundation. (2026). Interleukin-8 (IL-8 / CXCL8) in Gulf War Illness: direction, evidence and what it means. OSMF Research Tracker. Retrieved November 21, 2026, from https://research.opensourcemed.info/biomarkers/gulf-war-illness/interleukin-8-il-8-cxcl8.html

Last reviewed: 2026-06-29 · Page generated from gulf-war-illness.json · Browse: Gulf War Illness atlas · Biomarker Index · All marker pages

Disclaimer: This page is an educational synthesis of published, peer-reviewed research and is not medical advice. Biomarker findings vary across studies with case definitions, comparison groups, timing and assay methods. Direction of change reflects the predominant finding in the cited source and does not establish a diagnostic threshold. Discuss any test result with a qualified clinician.